Literature DB >> 18977068

Integrated backscatter and intima-media thickness of the thoracic aorta evaluated by transesophageal echocardiography in hypercholesterolemic patients: effect of pitavastatin therapy.

Koji Ono1, Masanori Kawasaki, Ryuhei Tanaka, Tomonori Segawa, Hitoshi Matsuo, Sachiro Watanabe, Genzou Takemura, Shinya Minatoguchi.   

Abstract

The effect of a strong, lipophilic statin (pitavastatin) on the thoracic aorta has not yet been elucidated. The purpose of the present study was to evaluate the effects of pitavastatin (P) therapy on plaque components and morphology in the thoracic aorta by transesophageal echocardiography (TEE) and clarify the impact of the therapy on media and intima in patients with hypercholesterolemia. Sixty-four media and 64 intima of the thoracic aorta were investigated in 32 patients with hypercholesterolemia. The corrected integrated backscatter (c-IBS) values in the thoracic aortic wall and intima-media thickness (IMT) at the same site were measured before and after P therapy or diet (D) for 7 mo. Moreover, c-IBS values in media were measured in 168 patients without hypercholesterolemia to estimate age-dependent changes. C-IBS values in media were correlated with age (r = 0.84, p < 0.001). C-IBS and IMT of media in the P group significantly decreased from -17.8 +/- 2.4 to -20.1 +/- 3.7 dB and from 1.7 +/- 0.3 to 1.5 +/- 0.3 mm, respectively (p < 0.001), whereas those in the D group significantly increased from -18.3 +/- 2.0 to -16.7 +/- 2.1 dB and from 1.6 +/- 0.3 to 1.7 +/- 0.2 mm, respectively (p < 0.001). IMT in intima in the P group significantly decreased from 3.7 +/- 0.4 to 3.3 +/- 0.4 mm (p < 0.001). C-IBS in intima in the P group significantly increased from -10.2 +/- 2.2 to -6.9 +/- 1.7 dB, which indicated plaque stabilization. Pitavastatin improved the atherosis measured by IMT and sclerosis measured by c-IBS values in the media and induced stabilization and regression of plaques in the intima of the thoracic aorta.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18977068     DOI: 10.1016/j.ultrasmedbio.2008.08.011

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  7 in total

1.  High HDL cholesterol level after treatment with pitavastatin is an important factor for regression in carotid intima-media thickness.

Authors:  Kenji Okumura; Hideto Tsukamoto; Hideyuki Tsuboi; Haruo Hirayama; Haruo Kamiya; Masato Watarai; Ryoji Ishiki; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2014-01-24       Impact factor: 2.037

Review 2.  Pitavastatin: a review of its use in the management of hypercholesterolaemia or mixed dyslipidaemia.

Authors:  Sean T Duggan
Journal:  Drugs       Date:  2012-03-05       Impact factor: 9.546

3.  Premature aortic atherosclerosis in systemic lupus erythematosus: a controlled transesophageal echocardiographic study.

Authors:  Carlos A Roldan; Joseph Joson; Janeen Sharrar; Clifford R Qualls; Wilmer L Sibbitt
Journal:  J Rheumatol       Date:  2009-12-01       Impact factor: 4.666

4.  Motion of left atrial appendage as a determinant of thrombus formation in patients with a low CHADS2 score receiving warfarin for persistent nonvalvular atrial fibrillation.

Authors:  Koji Ono; Makoto Iwama; Masanori Kawasaki; Ryuhei Tanaka; Takatomo Watanabe; Noriyuki Onishi; Shunichiro Warita; Tai Kojima; Takashi Kato; Yoshiaki Goto; Masazumi Arai; Kazuhiko Nishigaki; Genzou Takemura; Toshiyuki Noda; Sachiro Watanabe; Shinya Minatoguchi
Journal:  Cardiovasc Ultrasound       Date:  2012-12-27       Impact factor: 2.062

Review 5.  Pitavastatin approved for treatment of primary hypercholesterolemia and combined dyslipidemia.

Authors:  Jun Sasaki
Journal:  Vasc Health Risk Manag       Date:  2010-11-02

6.  Anti-inflammatory and morphologic effects of pitavastatin on carotid arteries and thoracic aorta evaluated by integrated backscatter trans-esophageal ultrasound and PET/CT: a prospective randomized comparative study with pravastatin (EPICENTRE study).

Authors:  Takatomo Watanabe; Masanori Kawasaki; Ryuhei Tanaka; Koji Ono; Nobuo Kako; Maki Saeki; Noriyuki Onishi; Maki Nagaya; Noriaki Sato; Hirotaka Miwa; Masazumi Arai; Toshiyuki Noda; Sachiro Watanabe; Shinya Minatoguchi
Journal:  Cardiovasc Ultrasound       Date:  2015-04-02       Impact factor: 2.062

7.  Left atrial pathological degeneration assessed by integrated backscatter transesophageal echocardiography as a predictor of progression to persistent atrial fibrillation: results from a prospective study of three-years follow-up.

Authors:  Tomoki Kubota; Masanori Kawasaki; Nobuhiro Takasugi; Hajime Imai; Yoshiyuki Ishihara; Munenori Okubo; Shigekiyo Takahashi; Hironobu Sato; Kazuhiko Nishigaki; Genzou Takemura; Shinya Minatoguchi
Journal:  Cardiovasc Ultrasound       Date:  2012-06-29       Impact factor: 2.062

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.